<DOC>
	<DOCNO>NCT01859949</DOCNO>
	<brief_summary>To assess long-term safety Genotropin ( somatropin ) Small Gestational Age ( SGA ) without epiphyseal closing .</brief_summary>
	<brief_title>Long Term Study Genotropin ( Somatropin ) Short Children Born Small Gestational Age ( SGA )</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<criteria>Children short stature due SGA receive treatment study GENASG0021002 . Children chronic disease require treatment steroid hormone may affect growth promotion include estrogen , androgen , anabolic hormone , corticosteroid ( except external use ) , receive treatment . Children receive radiotherapy chemotherapy . Children serious cardiac disease , renal disease , hepatic disease . Children diabetes mellitus manifestation abnormal glucose metabolism . Children serious chronic disease . Children malignant tumor . Children allergic mcresol .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Genotropin ( somatropin )</keyword>
	<keyword>SGA</keyword>
	<keyword>Short Stature</keyword>
	<keyword>Long-term</keyword>
	<keyword>Safety</keyword>
</DOC>